On March 10, the Department of Justice (DOJ) moved to drop a lawsuit filed on behalf of the Federal Trade Commission (FTC) against Xlear, ...

Don't let your spring break travel get ruined by illness or injury. Be prepared with these easily overlooked health ...

Rated 4.8 out of 5 stars on Amazon, these pocket-sized strips pack a powerful, nose-clearing punch that can do wonders for ...

treatment with saline-0.6% hydrogen peroxide and, if measles pneumonia present, with budesonide (0.5-1 mg/ml solution) Nasal sprays such as Xlear Rescue Nasal Spray or dilute betadine/saline spray.

Paratek Pharmaceuticals to acquire Optinose and its nasal drug-device Xhance for up to $330M, expanding beyond antibiotics ...

Xlear says the move calls FTC’s authority to require clinical studies for non-pharmaceutical health products into question.

DOJ ASKS COURT TO DISMISS FTC-XLEAR LAWSUIT; Calls into Question FTC’s Authority to Require Clinical Studies for Non-Pharmaceutical Health Products ...

Today, the Department of Justice asked the United States District Court, Utah, to dismiss the Federal Trade Commission’s lawsuit against Xlear, Inc. and Xlear CEO Nathan Jones. (At DOJ’s ...